Jansen-de Vries syndrome: Expansion of the PPM1D clinical and phenotypic spectrum in 34 families.


Journal

American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741

Informations de publication

Date de publication:
07 2023
Historique:
revised: 13 04 2023
received: 20 01 2023
accepted: 20 04 2023
pmc-release: 01 07 2024
medline: 8 6 2023
pubmed: 15 5 2023
entrez: 15 5 2023
Statut: ppublish

Résumé

Jansen-de Vries syndrome (JdVS) is a neurodevelopmental condition attributed to pathogenic variants in Exons 5 and 6 of PPM1D. As the full phenotypic spectrum and natural history remain to be defined, we describe a large cohort of children and adults with JdVS. This is a retrospective cohort study of 37 individuals from 34 families with disease-causing variants in PPM1D leading to JdVS. Clinical data were provided by treating physicians and/or families. Of the 37 individuals, 27 were male and 10 female, with median age 8.75 years (range 8 months to 62 years). Four families document autosomal dominant transmission, and 32/34 probands were diagnosed via exome sequencing. The facial gestalt, including a broad forehead and broad mouth with a thin and tented upper lip, was most recognizable between 18 and 48 months of age. Common manifestations included global developmental delay (35/36, 97%), hypotonia (25/34, 74%), short stature (14/33, 42%), constipation (22/31, 71%), and cyclic vomiting (6/35, 17%). Distinctive personality traits include a hypersocial affect (21/31, 68%) and moderate-to-severe anxiety (18/28, 64%). In conclusion, JdVS is a clinically recognizable neurodevelopmental syndrome with a characteristic personality and distinctive facial features. The association of pathogenic variants in PPM1D with cyclic vomiting bears not only medical attention but also further pathogenic and mechanistic evaluation.

Identifiants

pubmed: 37183572
doi: 10.1002/ajmg.a.63226
pmc: PMC10330231
mid: NIHMS1897407
doi:

Substances chimiques

PPM1D protein, human EC 3.1.3.16
Protein Phosphatase 2C EC 3.1.3.16

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1900-1910

Subventions

Organisme : NICHD NIH HHS
ID : K23 HD102589
Pays : United States
Organisme : NINDS NIH HHS
ID : K23 NS119666
Pays : United States
Organisme : NICHD NIH HHS
ID : P30 HD071593
Pays : United States
Organisme : NIMH NIH HHS
ID : R21 MH131740
Pays : United States

Informations de copyright

© 2023 Wiley Periodicals LLC.

Références

Pediatr Endocrinol Diabetes Metab. 2022;28(1):64-74
pubmed: 35307998
Nat Genet. 2019 Jan;51(1):106-116
pubmed: 30559488
Genet Med. 2019 Aug;21(8):1719-1725
pubmed: 30568311
Mol Genet Genomic Med. 2020 Mar;8(3):e1120
pubmed: 31916397
Blood. 2017 Aug 10;130(6):742-752
pubmed: 28483762
Am J Hematol. 2021 Jun 1;96(6):E207-E210
pubmed: 33725366
Nature. 2017 Feb 23;542(7642):433-438
pubmed: 28135719
Hum Mutat. 2017 May;38(5):517-523
pubmed: 28229513
Am J Hum Genet. 2017 Apr 6;100(4):650-658
pubmed: 28343630
Nat Commun. 2022 Feb 1;13(1):604
pubmed: 35105861
Am J Med Genet A. 2021 Oct;185(10):3028-3041
pubmed: 34355505
Nat Neurosci. 2016 Sep;19(9):1194-6
pubmed: 27479843
Neurologia (Engl Ed). 2021 May;36(4):330-332
pubmed: 32919790
Eur J Med Genet. 2019 Jan;62(1):70-72
pubmed: 29758292
Brain Dev. 2019 Jun;41(6):538-541
pubmed: 30795918
Sci Rep. 2022 Jun 30;12(1):11106
pubmed: 35773312
J Clin Lab Anal. 2020 Nov;34(11):e23480
pubmed: 32779812
J Hum Genet. 2019 Jun;64(6):545-550
pubmed: 30850729
Genet Med. 2021 Nov;23(11):2029-2037
pubmed: 34211152
Hum Mutat. 2015 Oct;36(10):928-30
pubmed: 26220891
J Formos Med Assoc. 2022 Apr;121(4):856-860
pubmed: 35016835
J Child Psychol Psychiatry. 2008 Jun;49(6):576-608
pubmed: 18489677
Am J Hum Genet. 2018 Aug 2;103(2):171-187
pubmed: 30032986
iScience. 2022 Aug 09;25(9):104892
pubmed: 36060052

Auteurs

Monica H Wojcik (MH)

Division of Newborn Medicine, Department of Pediatrics and Harvard Medical School, Boston Children's Hospital, Boston, Massachusetts, USA.
Division of Genetics and Genomics, Department of Pediatrics and Harvard Medical School, Boston Children's Hospital, Boston, Massachusetts, USA.
Manton Center for Orphan Disease Research, Boston Children's Hospital, Boston, Massachusetts, USA.

Siddharth Srivastava (S)

Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Pankaj B Agrawal (PB)

Manton Center for Orphan Disease Research, Boston Children's Hospital, Boston, Massachusetts, USA.
Division of Neonatology, Department of Pediatrics, Miller School of Medicine, University of Miami and Holtz Children's Hospital, Jackson Health System, Miami, Florida, USA.

Tugce B Balci (TB)

Medical Genetics Program of Southwestern Ontario, London Health Sciences Centre, London, Ontario, Canada.

Bert Callewaert (B)

Center for Medical Genetics, Pediatrics Department, Ghent University Hospital, Ghent, Belgium.

Pier Luigi Calvo (PL)

Pediatric Gastroenterology Unit, Regina Margherita Children's Hospital, Azienda Ospedaliera-Universitaria Città della Salute e della Scienza, Turin, Italy.

Diana Carli (D)

Department of Public Health and Pediatrics, University of Torino, Torino, Italy.

Michelle Caudle (M)

Medical Genetics Program of Southwestern Ontario, London Health Sciences Centre, London, Ontario, Canada.

Samantha Colaiacovo (S)

Medical Genetics Program of Southwestern Ontario, London Health Sciences Centre, London, Ontario, Canada.

Laura Cross (L)

Clinical Genetics, Children's Mercy Hospital, Kansas City, Missouri, USA.

Kalliope Demetriou (K)

Centre for Clinical Genetics, Sydney Children's Hospital, Sydney, New South Wales, Australia.

Katy Drazba (K)

Greenwood Genetic Center, Greenwood, South Carolina, USA.

Marina Dutra-Clarke (M)

Division of Genetics, Department of Pediatrics, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, USA.

Matthew Edwards (M)

Paediatrics, School of Medicine, Western Sydney University, Hunter Genetics, Newcastle, New South Wales, Australia.

Casie A Genetti (CA)

Division of Genetics and Genomics, Department of Pediatrics and Harvard Medical School, Boston Children's Hospital, Boston, Massachusetts, USA.
Manton Center for Orphan Disease Research, Boston Children's Hospital, Boston, Massachusetts, USA.

Dorothy K Grange (DK)

Division of Genetics and Genomic Medicine, Department of Pediatrics, Washington University School of Medicine, St Louis, Missouri, USA.

Scott E Hickey (SE)

Department of Pediatrics, The Ohio State University College of Medicine, Division of Genetic & Genomic Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA.

Bertrand Isidor (B)

Department of Medical Genetics, Nantes Hospital, Nantes, France.

Sébastien Küry (S)

Nantes Université, CHU Nantes, Service de Génétique Médicale, Nantes, France; Nantes Université, CHU Nantes, CNRS, INSERM, L'institut du thorax, Nantes, France.

Herbert M Lachman (HM)

Departments of Behavioral Science, Medicine, and Psychiatry, Albert Einstein College of Medicine, Bronx, New York, USA.

Alinoe Lavillaureix (A)

Service de Génétique Clinique, Centre de Référence Maladies Rares CLAD-Ouest, ERN ITHACA, CHU Rennes, Hôpital Sud, Rennes, France.

Michael J Lyons (MJ)

Greenwood Genetic Center, Greenwood, South Carolina, USA.

Carlo Marcelis (C)

Department of Human Genetics, Donders Centre for Neuroscience, Radboud University Medical Center, Nijmegen, The Netherlands.

Elysa J Marco (EJ)

Cortica Healthcare, Marin Center, San Rafael, California, USA.

Julian A Martinez-Agosto (JA)

Division of Genetics, Departments of Pediatrics and Human Genetics, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, USA.

Catherine Nowak (C)

Division of Genetics and Genomics, Department of Pediatrics and Harvard Medical School, Boston Children's Hospital, Boston, Massachusetts, USA.

Antonio Pizzol (A)

Pediatric Gastroenterology Unit, Regina Margherita Children's Hospital, Azienda Ospedaliera-Universitaria Città della Salute e della Scienza, Turin, Italy.

Marc Planes (M)

Service de Génétique Clinique, University Hospital Morvan, Brest, France.

Eloise J Prijoles (EJ)

Greenwood Genetic Center, Greenwood, South Carolina, USA.

Evelise Riberi (E)

Department of Public Health and Pediatrics, University of Torino, Torino, Italy.

Eric T Rush (ET)

UKMC School of Medicine, University of Missouri Kansas City, Kansas City, Missouri, USA.
Division of Genetics, Children's Mercy Kansas City, Kansas City, Missouri, USA.
Department of Internal Medicine, University of Kansas School of Medicine, Kansas City, Missouri, USA.

Bianca E Russell (BE)

Division of Genetics, Departments of Pediatrics and Human Genetics, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, USA.

Rani Sachdev (R)

Centre for Clinical Genetics, Sydney Children's Hospital, Sydney, New South Wales, Australia.
School of Women's and Children's Health, University of New South Wales, Sydney, New South Wales, Australia.

Betsy Schmalz (B)

Department of Pediatrics, The Ohio State University College of Medicine, Division of Genetic & Genomic Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA.

Deborah Shears (D)

Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

David A Stevenson (DA)

Division of Medical Genetics, Department of Pediatrics, Stanford University, Stanford, California, USA.

Kate Wilson (K)

Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Sandra Jansen (S)

Donders Centre for Neuroscience, Radboud University Medical Center, Nijmegen, The Netherlands.

Bert B A de Vries (BBA)

Donders Centre for Neuroscience, Radboud University Medical Center, Nijmegen, The Netherlands.

Cynthia J Curry (CJ)

Genetic Medicine, Department of Pediatrics, University of California San Francisco/Fresno, Fresno, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH